Hybridomas producing antibodies specific for lyme disease antige

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303895, 4351722, 435339, 435340, 4241501, 4241641, 4242341, A61K 31395

Patent

active

058564470

ABSTRACT:
The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.
The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies, hybridomas and antigens.

REFERENCES:
patent: 5178859 (1993-01-01), Simon et al.
patent: 5434077 (1995-07-01), Simon et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hybridomas producing antibodies specific for lyme disease antige does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybridomas producing antibodies specific for lyme disease antige, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridomas producing antibodies specific for lyme disease antige will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-863449

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.